SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001256088-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
38,950
Total Value
$194,700.00
P&L
+inf% (+$213,726.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 23, 2026 | Exercise/Conversion | 15,000 | $12.98 | $194,700.00 | 33,684 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 24, 2026 | Grant/Award | 4,475 | $0.00 | $0.00 | 38,159 | Direct | โ | View Details | |
Director | Director Stock Option (Right to Buy) | Derivative | Mar 1, 2017 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 24, 2026 | Sale to Issuer | 4,475 | $0.00 | $0.00 | 0 | Direct | โ | View Details |